As research leaders in Life Sciences, we have known for a long time that infectious diseases affecting humans, animals and plants are a challenge for global health, food security and well-being.
We have also known for a long time that as part of the microbiota, beneficial microbes have evolved mechanisms to fight infectious diseases.
Today, as entrepreneurial researchers we want to do something about it. This is why we created microXpace: we aim at developing transformative microbial technologies to improve health and food production in a sustainable manner.
For the next few years,
our ambition is to make a global impact on humanity.
Our mission is to put transformative microbial technologies
in the hands of those who needs them more.
Harnessing the power of natural antibodies to fight infectious diseases affecting aquaculture and poultry industries.
Gut beneficial bacteria have evolved for millions of years within their vertebrate hosts such as fish, birds and humans. The symbiotic relationship between microbes and animals survived natural selection because the microbiota protects the host against major threats such as infectious diseases. Bacteria in the gut microbiota express the glycan alpha-Gal, and induce the production of natural anti-alpha-Gal antibodies.
A group of researchers (some of them co-founders of microXpace) discovered that natural anti-alpha-Gal antibodies can kill major pathogens affecting fish, birds and humans alike. We also learned to modulate the natural immune response to alpha-Gal and put the animal in a 'ready-to-fight' state protecting it against several pathogens simultaneously.
microXpace is using a patented technology to, together with our biotech partner Lallemand,
develop a collection of products to protect fish and birds against major parasitic and infectious diseases
The envisaged product will be completely safe and environmentally friendly.
The only way to meet the challenges ahead is to build communities of people and institutions with shared values and commitments, is to remove boundaries that limit human creativity.
Bringing innovation to practical use requires a common effort of teams with complementary skills.
microXpace is proud of its community that includes academic institutions and biotech companies as well as remarkable individuals.
microXpace created the Microbiome Research Centre to unlock the knowledge through community building and reveal untapped biological innovations contained within a wide range of microbial species.
CEO of microXpace and chief researcher at the P.B. Šivickis Parasitology Laboratory of the Nature Research Centre, Vilnius, Lithuania. He is a highly accomplished parasitologist working on avian blood parasites with more than 10 years of experience and more than 70 publications in scientific journals. In recent years, studies focused on genetic factors and their impact on the virulence of avian malarial parasites, ecological factors important for the spread of vector-borne pathogens, and the role of microbiota in pathogen development and transmission. In 2018 he was elected to the Young Academy of the Lithuanian Academy of Sciences and served as Chair of the Young Academy in 2022. He has also been vice president of the Scandinavian-Baltic Society for Parasitology since 2013.
Principal investigator at the French National Research Institute for Agriculture, Food and the Environment (INRAE). Alejandro graduated as a veterinarian and has 15+ years of experience as a scientist with big contributions to the study of α-Gal immunity and vector-borne diseases. He has more than 160 publications and received the ‘Odile Bain Memorial Prize’ (OBMP) 2017 for his outstanding contribution in the field of parasitology. Dr. Cabezas-Cruz is the inventor of two patents. Alejandro holds an MSc in Parasitology from the University of South Bohemia, Czech Republic, and two PhDs from the University of Lille, France, and the University of Castilla-La Mancha, Spain.
CEO of microXpace and Head of Fish Protistology at the Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, is a parasitologist with experience in molecular host-parasite interactions as well as parasite transmission ecology. She focusses on the development of anti-parasitic strategies via functional diets and vaccines for aquaculture. She contributes to large EU-funded efforts aiming at controlling parasite burdens in fish and to the development of commercial products with several industrial partners.
Veterinarian and scientist with 15+ years of experience in preventive veterinary medicine and microbial ecology. He is an internationally recognized researcher in the field of ecoepidemiology of vector-borne diseases and the host-microbiota-pathogen interactions with outstanding scientific contributions. Dr. Dasiel is passionate about exploring multi-omics data, microbiome analyses, and discovering microbial-based solutions to animal health issues. Dr. Dasiel holds an MSc in Preventive Veterinary Medicine from the Agrarian University of Havana (UNAH), Cuba, and two PhDs, one in Animal Health from the National Center for Animal and Plant Health (CENSA), Cuba, and the other in Microbial Ecology from the University of São Paulo (USP), Brazil.
Research Director at the French National Institute of Agricultural Research (INRAE), is a molecular microbiologist with 20 years of experience in probiotics, commensals, and recombinant bacteria (recLAB). He is an international leader in the field of host-bacteria interactions and isolation and characterization of novel bacterial strains for the development of probiotic supplements for human and animal health with more than 120 publications on these topics and 8 patents. His outstanding scientific contributions have been recognized by the scientific community with several international honours and awards.
Researcher at the French Institute of Health and Medical Research (INSERM), is an immunologist with many years of experience in cancer research, vaccines, but also mucosal immunology. She conducted her PhD thesis in Nantes, France, on cancer immunology. She developed her expertise in some prestigious institutions in France, such as the Curie Institute, the Pasteur Institutes (Paris and Lille), but also abroad, at Oxford University and at the University College of London.
Veterinarian and scientist with 15+ years of experience in clinical sciences and animal behaviour. He conducted his PhD thesis on the behaviour of buffaloes and Cattle in tropical environments. Maykel is an entrepreneur at heart and currently has his veterinary clinic in Mungia, Spain. Maykel has an MSc in Animal nutrition from the University of Matanzas, Cuba, and a PhD from the University of Cordoba, Spain.
Veterinarian and scientist with 10+ years of experience in experimental and clinical parasitology. He is an EBVS® European Veterinary Specialist in Parasitology (Dipl. EVPC) and an international leader in the field of parasitology, with a focus on α-Gal immunity and vector-borne diseases. Dr. Hodžić is the co-inventor of one patent. His outstanding scientific contributions have been recognized by two international awards (Sinnecker-Kunz Award 2019 and Odile Bain Memorial Prize 2020). Adnan holds an MSc in Veterinary Parasitology from the University of Sarajevo, Bosnia and Herzegovina, and a PhD from the University of Veterinary Medicine Vienna, Austria.